Early One-Cycle Post-Neoadjuvant Chemotherapy Volumetric and SER-based Changes on DCE-MRI: Timely Predictors of Response and Prognosis in Breast Cancer
This study demonstrates that early volumetric and signal enhancement ratio-based functional tumor volume reductions observed on DCE-MRI after just one cycle of neoadjuvant chemotherapy serve as superior predictors of clinical response and recurrence-free survival compared to traditional size-based metrics or later assessments in breast cancer patients.